Changying Li

1.2k citations
44 papers · 925 indexed · h-index 21
Topics
Cancer-related molecular mechanisms research (9 papers)Prostate Cancer Treatment and Research (5 papers)Bladder and Urothelial Cancer Treatments (4 papers)

In The Last Decade

Changying Li

44 papers receiving 913 citations

Peers

Changying Li
Comparison fields: 5 of 106
  • Molecular Biology 451
  • Cancer Research 333
  • Surgery 172
  • Pulmonary and Respiratory Medicine 150
  • Oncology 102
Replace Liang Zhu with:
Liang Zhu China
Hongliang Wang China
Cristiana Griffoni Italy
Yu‐Zheng Ge China
Liqin Xu China
Hui Jing China
Zhenwu Du China
Chao Song China
Peipei Guo China
Changying Li relative to Liang Zhu China Liang Zhu's profile →
Citations per field
00.5×1.5×
Liang Zhu · 1×
Citations per year

Countries citing papers authored by Changying Li

Since Specialization
Citations

This map shows the geographic impact of Changying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changying Li more than expected).

Fields of papers citing papers by Changying Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changying Li. The network helps show where Changying Li may publish in the future.

Co-authorship network of co-authors of Changying Li

This figure shows the co-authorship network connecting the top 25 collaborators of Changying Li. A scholar is included among the top collaborators of Changying Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changying Li. Changying Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 3
3 13
4 3
5 31
6 21
7 7
8 26
9 20
10 37
11 31
12 1
13 11
14 59
15 39
16 28
17 32
18 8
19 39
20
The distribution of killer immunoglobulin-like receptor genes in Qingdao Han population
2

About Changying Li

Changying Li is a scholar working on Cancer Research, Immunology and Anesthesiology and Pain Medicine, having authored 44 papers that have together received 925 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Prostate Cancer Treatment and Research (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Cancer Research (333 citations), Molecular Biology (451 citations) and Urology (30 citations). Changying Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Jiwu Chang, Ming Gao, Sijin Liu, Ming Xu, Yun Liu, Hongjie Li, Ting Zhang, Min Cong, Haitao Wang and Jianmin Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026